Transcriptionally-activated AAV inverted terminal repeats (ITRs) for use with recombinant AAV vectors
AL Feldhaus - US Patent 6,936,466, 2005 - Google Patents
US6936466B2 - Transcriptionally-activated AAV inverted terminal repeats (ITRs) for use with
recombinant AAV vectors - Google Patents US6936466B2 - Transcriptionally-activated AAV …
recombinant AAV vectors - Google Patents US6936466B2 - Transcriptionally-activated AAV …
SP35 antibodies and uses thereof
S Mi, RB Pepinsky, Z Shao, C Graff - US Patent 8,551,476, 2013 - Google Patents
US8551476B2 - SP35 antibodies and uses thereof - Google Patents US8551476B2 - SP35
antibodies and uses thereof - Google Patents SP35 antibodies and uses thereof Download …
antibodies and uses thereof - Google Patents SP35 antibodies and uses thereof Download …
Composition comprising antibodies to LINGO or fragments thereof
S Mi, RB Pepinsky, C Graff - US Patent 8,058,406, 2011 - Google Patents
A61K47/50—Medicinal preparations characterised by the non-active ingredients used, eg
carriers or inert additives; Targeting or modifying agents chemically bound to the active …
carriers or inert additives; Targeting or modifying agents chemically bound to the active …
Composition comprising antibodies to LINGO or fragments thereof
S Mi, RB Pepinsky, C Graff - US Patent 8,425,910, 2013 - Google Patents
US8425910B2 - Composition comprising antibodies to LINGO or fragments thereof - Google
Patents US8425910B2 - Composition comprising antibodies to LINGO or fragments thereof …
Patents US8425910B2 - Composition comprising antibodies to LINGO or fragments thereof …
Sp35 antibodies and uses thereof
S Mi, RB Pepinsky, Z Shao, EA Garber… - US Patent …, 2012 - Google Patents
Endogenous Sp35 is a negative regulator for neuronal survival, axon regeneration,
oligodendrocyte differentiation and myelination. Molecules that block endogenous Sp35 …
oligodendrocyte differentiation and myelination. Molecules that block endogenous Sp35 …
Sp35 antibodies and uses thereof
S Mi, RB Pepinsky, Z Shao, C Graff - US Patent 9,066,984, 2015 - Google Patents
US9066984B2 - Sp35 antibodies and uses thereof - Google Patents US9066984B2 - Sp35
antibodies and uses thereof - Google Patents Sp35 antibodies and uses thereof Download PDF …
antibodies and uses thereof - Google Patents Sp35 antibodies and uses thereof Download PDF …
Methods for Treating Pressure Induced Optic Neuropathy, Preventing Neuronal Degeneration and Promoting Neuronal Cell Survival Via Administration of LINGO-1 …
S Mi - US Patent App. 12/682,505, 2010 - Google Patents
This invention relates to methods for promoting neuronal survival and regeneration using
LINGO-1 antagonists and TrkB agonists. Additionally, the invention relates to methods for …
LINGO-1 antagonists and TrkB agonists. Additionally, the invention relates to methods for …
Treatment of conditions involving demyelination
S Mi, RB Pepinsky, J Mccoy - US Patent 8,486,893, 2013 - Google Patents
US8486893B2 - Treatment of conditions involving demyelination - Google Patents
US8486893B2 - Treatment of conditions involving demyelination - Google Patents Treatment of …
US8486893B2 - Treatment of conditions involving demyelination - Google Patents Treatment of …
Nogo receptor binding protein
S Mi, J McCoy, RB Pepinsky, DHS Lee - US Patent 7,785,829, 2010 - Google Patents
The invention provides Sp35 polypeptides and fusion proteins thereof, Sp35 antibodies and
antigen-binding fragments thereof and nucleic acids encoding the same. The invention also …
antigen-binding fragments thereof and nucleic acids encoding the same. The invention also …
Use of lingo-4 antagonists in the treatment of conditions involving demyelination
S Mi, RB Pepinsky, J McCoy - 2015 - Google Patents
EP2217697B1 - Use of lingo-4 antagonists in the treatment of conditions involving
demyelination - Google Patents EP2217697B1 - Use of lingo-4 antagonists in the treatment of …
demyelination - Google Patents EP2217697B1 - Use of lingo-4 antagonists in the treatment of …